European Archives - Page 8 of 1492 - European Medical Journal

Microbiome Maturation Influences Neurodevelopmental Disorder Risk

Researchers investigate how specific gut bacteria might modify the impact of perinatal epigenetic changes associated with neurodevelopmental disorders.

Brain Imaging Predicts Ketamine Response in Depression

Brain imaging combined with machine learning predicted ketamine response in patients with treatment-resistant depression, supporting more personalised care.

CAR-T Trial Access Lower for People With HIV

People living with HIV face significantly longer travel times and reduced access to CAR-T clinical trials for non-Hodgkin lymphoma, with disparities most pronounced in the southern United States.

Plant-Based Diet Reduces Mortality in CKD

Plant-Based Diet Linked to Lower Mortality in CKD: ERA 2026

A plant-based dietary pattern was associated with lower all-cause and renal-related mortality in patients with chronic kidney disease.

Antidiabetic Drugs Target Urinary E. coli - EMJ

A prospective cohort study found that maternal diabetics show elevated levels of the inflammation marker C reactive protein.

European Experts Call for Women’s Heart Centres - EMJ

European Experts Unveil Blueprint for Women’s Heart Centres

A new European consensus statement outlined how women’s heart centres could improve diagnosis, treatment, and prevention of cardiovascular disease in females.

White DNA helix on blue background

FDA unveils new plan for genome therapy editing

The guidance allows sponsors to build on data generated from previous R&D programmes.

Finerenone Benefits Non-Diabetic CKD Patients

Finerenone Slows Kidney Function Decline in Non-Diabetic CKD: ERA 2026

Finerenone significantly slowed kidney function decline and reduced cardiovascular-kidney risk in patients with non-diabetic CKD in the FIND-CKD trial.

Phototherapy Safety In Elderly Psoriasis Patients - EMJ

Phototherapy Remains Effective and Safe in Elderly Psoriasis Patients

Phototherapy shows similar efficacy in elderly and younger psoriasis patients, with fewer side effects in older adults. Read more.

DCCBs and Kidney Risk in Type 2 Diabetes - EMJ

Blood Pressure Drug Linked to Worse Kidney Outcomes in T2D: ERA 2026

New ERA Congress research suggests DCCBs may be linked to worse kidney outcomes in patients with Type 2 diabetes despite standard therapies.